Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05917184 · ClinicalTrials.gov registry record
The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 52
- Enrollment target
NCT05917184 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 52 participants.
The verdict
NCT05917184 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
The goal of this pilot study is to determine the reliability of myasthenia gravis (MG) specific outcome measures obtained during virtual encounters with patients with myasthenia gravis. The main question it aims to answer is: Are MG-specific outcome measures obtained during virtual encounters reliable? Participants will complete two virtual study visits in which they will be administered common MG-specific outcome measures and a newly developed outcome measure developed specifically for telemedicine assessments of MG patients.
Interventions
- OTHER Telehealth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2021-08-30 |
| Est. Completion | 2023-01-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05917184
The ClinicalTrials.gov registry entry for NCT05917184 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telehealth is the first listed.
NCT05917184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05917184 about?
NCT05917184 is a clinical study titled "The Adapting Disease Specific Outcome Measures Pilot Trial for Telehealth in Myasthenia Gravis". The goal of this pilot study is to determine the reliability of myasthenia gravis (MG) specific outcome measures obtained during virtual encounters with patients with myasthenia gravis. The main question it aims to answer is: Are MG-specific outcome measures obtained during virtual encounters reliab...
What is the current status of trial NCT05917184?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2021-08-30. Estimated completion is 2023-01-20.
What interventions are being tested in trial NCT05917184?
The interventions under investigation include: Telehealth (OTHER).
Who is sponsoring clinical trial NCT05917184?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.